You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 21, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Ritika Uppal1, Kate L Ciesienski, Daniel B Chonde
1A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Suite 2301, Charlestown, Massachusetts 02129, USA.
This article describes a new method for creating specialized imaging tools designed to find blood clots. These tools, called bimodal probes, combine two different types of signals to help doctors see clots more clearly. By attaching a specific protein-binding molecule to two different imaging markers, the researchers created a versatile system. Laboratory tests confirmed that these tools successfully stick to fibrin, a key component of clots. The probes work across several common medical imaging technologies, including magnetic resonance and positron emission tomography. This innovation provides a flexible platform for improving how clinicians identify and monitor thrombosis. The approach allows for consistent performance across a broad range of concentrations. Overall, this development offers a promising path for more accurate clot visualization in clinical settings.
Area of Science:
Background:
No prior work had resolved the challenge of creating versatile, discrete imaging agents for blood clots. Current diagnostic tools often lack the flexibility required for multi-modal detection of fibrin networks. That uncertainty drove the need for a standardized chemical approach to probe development. Prior research has shown that fibrin serves as a primary target for identifying thrombus formation. However, existing methods for attaching multiple reporters to targeting molecules remain cumbersome and inconsistent. This gap motivated the development of a robust synthesis strategy for bimodal agents. Scientists require reliable probes that maintain high affinity for their biological targets while providing clear signals. Establishing a uniform production method could significantly enhance the precision of cardiovascular diagnostic imaging.
Purpose Of The Study:
The aim of this research is to develop a generalizable synthesis strategy for discrete bimodal fibrin-targeted imaging probes. Scientists face a persistent challenge in creating versatile agents that can be detected by multiple imaging modalities. This study addresses the need for a standardized chemical approach to attach two distinct reporters to a single targeting peptide. The researchers seek to ensure that these modifications do not compromise the affinity of the probe for its biological target. By focusing on the C- and N-termini, the team explores a precise method for dual-labeling. This investigation is motivated by the requirement for more accurate and flexible tools in cardiovascular diagnostics. The authors intend to demonstrate that their probes function reliably across a broad range of concentrations. Ultimately, the work establishes a foundation for creating multifunctional agents that improve the visualization of fibrin networks.
Main Methods:
Review Approach framing involves a solid/solution-phase chemical synthesis protocol. The team conjugates a fibrin-specific peptide to two separate reporters. They place these markers at the C- and N-termini of the targeting molecule. This design ensures the production of discrete, uniform imaging agents. The researchers evaluate the binding affinity of the resulting constructs using standard laboratory assays. They perform imaging experiments to test the performance of the probes across different concentrations. The study utilizes optical, magnetic resonance, and positron emission tomography systems for signal acquisition. This comprehensive testing approach validates the functionality of the synthesized tools in controlled environments.
Main Results:
Key Findings From the Literature indicate that the synthesized probes successfully retain their affinity for fibrin. The researchers demonstrate that these tools effectively target the protein in laboratory settings. Imaging experiments show that the probes provide detectable signals across a wide range of concentrations. The study confirms that the dual-reporter design is compatible with optical, magnetic resonance, and positron emission tomography modalities. These results show that the probes maintain specificity even after the conjugation of multiple imaging reporters. The data suggest that the synthesis strategy produces consistent and reliable agents for diagnostic use. The findings highlight the versatility of the probes in detecting fibrin networks. This performance remains stable across the tested experimental conditions.
Conclusions:
The authors propose that their synthesis strategy provides a reliable platform for creating fibrin-targeted imaging agents. This approach allows for the attachment of distinct reporters at specific molecular ends. Synthesis and Implications suggest that these probes maintain their binding capabilities despite the addition of dual imaging markers. The researchers demonstrate that their tools function effectively across diverse diagnostic modalities. These findings indicate that the probes remain sensitive to fibrin even when concentrations vary significantly. The study confirms that optical, magnetic resonance, and positron emission tomography signals are all achievable with this design. These results highlight the potential for improved thrombus visualization in clinical research environments. The team concludes that their method offers a flexible foundation for future diagnostic probe development.
The researchers propose that the probes function by binding specifically to fibrin. This interaction allows for detection via optical, magnetic resonance, and positron emission tomography signals. Unlike traditional single-mode agents, these bimodal tools provide dual-reporter capabilities for enhanced diagnostic clarity.
The team utilizes a fibrin-specific peptide as the targeting component. This peptide is synthesized with two distinct imaging reporters attached to the C- and N-termini. This dual-attachment design ensures that the targeting molecule remains functional while carrying the necessary signal-generating labels.
The authors explain that the solid/solution-phase strategy is necessary to ensure the production of discrete, well-defined molecules. This technical requirement prevents the formation of heterogeneous mixtures, which would otherwise complicate the interpretation of imaging data during clinical or laboratory applications.
The researchers employ a peptide-based targeting sequence to achieve high specificity. This data type acts as the biological anchor, ensuring the reporters localize accurately to the clot. By contrast, non-targeted imaging agents often suffer from high background noise and poor signal-to-noise ratios.
The study measures the affinity and specificity of the probes using in vitro binding assays. These experiments confirm that the conjugated molecules retain their ability to recognize fibrin. This measurement is critical for validating that the chemical modifications do not interfere with the probe's biological performance.
The authors suggest that this platform could improve the accuracy of thrombus detection. They propose that the ability to use multiple imaging modalities provides a more comprehensive view of clot composition compared to standard single-modality approaches. This flexibility may assist in better monitoring of cardiovascular conditions.